Savella Approval History

• FDA approved: Yes (First approved January 14th, 2009)
• Brand name: Savella
• Generic name: milnacipran
• Company: Forest Laboratories, Inc. and Cypress Bioscience, Inc.
• Treatment for: Fibromyalgia

Savella (milnacipran) is a selective serotonin and norepinephrine reuptake inhibitor indicated for the management of fibromyalgia.

FDA Approval History for Savella

Date	Article
Jan 15, 2009	Forest and Cypress Announce FDA Approval of Savella for the Management of Fibromyalgia
Oct 20, 2008	FDA Defers Final Action on Milnacipran New Drug Application
Feb 21, 2008	Forest and Cypress Announce FDA Acceptance for Review of New Drug Application for Milnacipran for the Treatment of Fibromyalgia
Jan  2, 2008	Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome

See also...

Savella (milnacipran) Consumer Information

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.